Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07203144 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Selenium Supplementation for Improving Depression in Children and Adolescents: Efficacy and Mechanistic Study

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 1 of 2 changed
Primary endpoint added 1 → 2 primary endpoints
See other at-risk trials from First Affiliated Hospital of Chongqing Medical University

Record History

  1. Primary endpoint(s) modified Secondary endpoints revised (9)v5 Show 1 more changeShow less
    • Secondary endpoints revised (9)

    See this version in full on ClinicalTrials.gov ↗

  2. Primary endpoint(s) modified Recruitment opened · Secondary endpoints: 8 to 9 · Site details revised · 2 morev4 Show 5 more changesShow less
    • Recruitment opened
    • Secondary endpoints: 8 to 9
    • Site details revised
    • Eligibility criteria shortened, about 1 word
    • Study description shortened, about 5 words

    See this version in full on ClinicalTrials.gov ↗

  3. Study description revisedv3 See this version in full on ClinicalTrials.gov ↗
  4. Start date: Oct 1, 2025 to Dec 31, 2025 Eligibility criteria revised · Secondary endpoints: details revised at 6 of 8 entries · Publications: details revised at 16 of 16 entriesv2 Show 3 more changesShow less
    • Eligibility criteria revised
    • Secondary endpoints: details revised at 6 of 8 entries
    • Publications: details revised at 16 of 16 entries

    See this version in full on ClinicalTrials.gov ↗

  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to investigate the role and mechanisms of selenium in depression among children and adolescents, aiming to provide new insights for understanding the pathogenesis and treatment of depression in this population.
Trial Details
NCT Number NCT07203144
Lead Sponsor First Affiliated Hospital of Chongqing Medical University
Conditions Depression - Major Depressive Disorder
Enrollment 172 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov